Concepedia

Sameer Kawatkar

SK

Statistics

Publications

22

Citations

1.3K

H-Index

20

Active since

2002

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

University of Georgia

AstraZeneca (South Korea)

Sanford Burnham Prebys Medical Discovery Institute

Sameer Kawatkar is an author at AstraZeneca (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2002–2023

22

Publications

22

EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex

Jessie Hao-Ru Hsu, Timothy Rasmusson, James Robinson et al. · Cell chemical biology · 2019 · 197 citations · Full text

, , +5

Practical Approach for the Stereoselective Introduction of β-Arabinofuranosides

Xiangming Zhu, Sameer Kawatkar, Geert‐Jan Boons · Journal of the American Chemical Society · 2006 · 148 citations

, , +15

Stereoselective Glycosylations of 2-Azido-2-deoxy-glucosides Using Intermediate Sulfonium Ions

Jin Park, Sameer Kawatkar, Jin-Hwan Kim et al. · Organic Letters · 2007 · 140 citations · Full text

, , +17

Practical Approach for the Stereoselective Introduction of β‐Arabinofuranosides.

Xiangming Zhu, Sameer Kawatkar, Yu Rao et al. · ChemInform · 2006 · 117 citations · Full text

, , +6

Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide

Sameer Kawatkar, Hongming Wang, Ryszard Czermiński et al. · Journal of Computer-Aided Molecular Design · 2009 · 97 citations

, , +9

1–5 of 22